Comparative assessment of cardiometabolic risk factor role in high-stress occupations
https://doi.org/10.15829/1728-8800-2012-3-53-57
Abstract
Aim. To investigate the components of metabolic syndrome (MS) and to evaluate the role of cardiometabolic risk factors (RFs) in high-stress vs. low-stress occupations, in order to enable early diagnostics of the most important factors.
Material and methods. In total, 299 men were examined (mean age 43,25±7,75 years). Group I worked as train drivers (n=185), while Group II included railway track workers (n=114). All participants underwent clinical examination, measurement of body mass index, waist circumference (WC), office blood pressure (BP), blood glucose, and lipid profile. MS was diagnosed according to the criteria by IDF (2005), ATP III (2005), and the Society of Cardiology of the Russian Federation (2009).
Results. Group I, compared to Group II, demonstrated higher prevalence (p<0,05) of smoking (+22%); abdominal obesity (AO), as denoted by WC ≥94 cm (+28%) or WC 94-102 cm (+16%); elevated systolic BP, SBP (+36%); total cholesterol, TCH (+12%) and very low density lipoprotein cholesterol, VLDL-CH (+16%). The most prevalent combination of MS components among individuals in a high-stress occupation was AH and AO. In Group I, MS prevalence ranged from 30% to 49% (p<0,05) and was 2,5-2,7 times higher than in Group II (p<0,001).
Conclusion. Individuals in high-stress occupations demonstrated high prevalence of cardiometabolic RFs and MS. Based on strict MS criteria, early preventive measures among people in high-stress occupations should target individuals with WC 94-102 cm combined with other cardiovascular RFs.
About the Authors
I. V. OsipovaRussian Federation
G. I. Simonova
Russian Federation
I. V. Kalinina
Russian Federation
O. N. Antropova
Russian Federation
A. G. Osipov
Russian Federation
I. N. Komissarova
Russian Federation
A. G. Salzman
Russian Federation
References
1. Briel M., Ferreira-Gonzalez I., You J.J., et al. Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis. BMJ 2009; 338: b92. doi: 10.1136/bmj.b92.
2. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002; 287 (3): 356-9.
3. Kubansky L., Kawachi I., Weiss I., et al. Anxiety and coronary heart disease a synthesis of epidemiological, psychological, and experimental evidence. Ann Behav Med 1998; 20(2): 47-58.
4. Mamedov M.N, Perova N.V., Oganov R.G. Lipid abnormalities in Russian hypertensive patients: role in metabolic syndrome atherogenicity. Advances in Lipoprotein and Atherosclerosis Research, Diagnostics and Treatment. Proc. 9th Intern. Dresden Lipid Symp 1997; 186-91.
5. Bombelli M.G., Facchetti C.G., Giannattasio M.F. Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life bloodpressure, cardiac damage, and prognosis. Hypertension 2007; 49: 40-7.
6. Stroes E.S., Koomans H.A., de Bmin T.W.A., Rabelink T.J. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet 1995; 346: 467-71.
7. Osipova I.V., Antropova O.N., Zal´cman A.G., et al. Hypertension at the workplace: Diagnosis. Features of the flow. Treatment. Prevention: Barnaul, 2010; 274 p. Russian (Осипова И.В., Антропова О.Н., Зальцман А.Г., Воробьева Е.Н. Гипертония на рабочем месте: Диагностика. Особенности течения, Лечение. Профилактика: Барнаул, 2010; 274 с).
8. Diagnosis and treatment of metabolic syndrome. Russian advice. Cardiovascular Therapy and Prevention 2009; 8(6): Application 2, 4-26. Russian (Диагностика и лечение метаболического синдрома. Российские рекомендации. Кардиоваскулярная терапия и профилактика 2009; 8(6) Приложение 2, 4-26 с).
9. Kobalava J.D., Kotovskaya Y.V., Moiseev V.S. Hypertension. Keys to diagnosis and treatment. M.: GEOTAR-Media 2009; 864 p. Russian (Кобалава Ж.Д., Котовская Ю.В., Моисеев B.C. Артериальная гипертония. Ключи к диагностике и лечению. М.: ГЭОТАР-Медиа 2009; 864 с).
10. Cfasman A.Z., Gutnikov O.V., Atókova E.O. Antihypertensive drugs and psychophysiological quality of drivers. M.:MCNMO 2005; 170 p. Russian (Цфасман А.З., Гутников О.В., Атькова Е.О. Антигипертензивные препараты и психофизиологические качества водителей. М.: МЦНМО 2005; 170 с).
11. Karasek R.A., Theorell T., WHO, Copenhagen. Current issues relating to psychosocial job strain and cardiovascular disease research. J Occupat Hith Psychol 1996; 1: 9-26.
12. Cfasman A.Z. Professional cardiology. Moscow: 2007; 208 p. Russian (Цфасман А.З. Профессиональная кардиология. Москва 2007; 208 с).
13. Shljahto E.V., Konradi A.O., Rotar’ O.P., et al. Criteria of the metabolic syndrome. The value of selection criteria for prevalence estimates. Arterial hypertension 2009; 15(4): 409-12. Russian (Шляхто Е.В., Конради А.О., Ротарь О.П., Солнцев В.Н. к вопросу о критериях метаболического синдрома. Значение выбора критерия для оценки распространенности. Артер гиперт 2009; 15(4): 409-12).
Review
For citations:
Osipova I.V., Simonova G.I., Kalinina I.V., Antropova O.N., Osipov A.G., Komissarova I.N., Salzman A.G. Comparative assessment of cardiometabolic risk factor role in high-stress occupations. Cardiovascular Therapy and Prevention. 2012;11(3):53-57. (In Russ.) https://doi.org/10.15829/1728-8800-2012-3-53-57